APA
BEAM icon

American Portfolios Advisors’s Beam Therapeutics BEAM Stock Holding History

American Portfolios Advisors’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$21.4K Buy
+450
New +$25.7K ﹤0.01% 2152
2022
Q1 		– Sell
-175
Closed -$13.9K – 3590
2021
Q4 		$13.9K Hold
175
– – ﹤0.01% 2493
2021
Q3 		$15.2K Sell
175
-6
-3% -$603 ﹤0.01% 2396
2021
Q2 		$23.3K Buy
181
+25
+16% +$1.99K ﹤0.01% 2153
2021
Q1 		$12.5K Sell
156
-25
-14% -$2.38K ﹤0.01% 2281
2020
Q4 		$14.8K Buy
+181
New +$8.9K ﹤0.01% 1950

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Portfolios Advisors's BEAM Position: Q3 2022 in Review

American Portfolios Advisors opened a new position in Beam Therapeutics (BEAM) in Q3 2022: 450 shares worth $21.4K. The stake represents ﹤0.01% of the portfolio and ranks #2152 among its holdings. This is a return to the name: American Portfolios Advisors previously reported a position in BEAM as recently as Q4 2021.

American Portfolios Advisors first reported a position in BEAM in Q4 2020 and has held it in 6 quarters since. The position peaked at $23.3K in Q2 2021. 224 funds tracked by Wall St. Rank hold BEAM as of Q3 2022.

  • American Portfolios Advisors held 450 shares of Beam Therapeutics worth $21.4K as of Q3 2022.
  • Beam Therapeutics was a new American Portfolios Advisors position in Q3 2022.
  • Beam Therapeutics made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2152 holding.
  • American Portfolios Advisors first reported a position in Beam Therapeutics in Q4 2020 and has held it in 6 quarters since.
  • American Portfolios Advisors's Beam Therapeutics position peaked at $23.3K in Q2 2021.
  • 224 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.